Investors

AMAG is a biopharmaceutical company focused on bringing therapeutics to market that provide clear benefits and help improve people’s lives, all while delivering value to our shareholders.

Headquartered in Waltham, Massachusetts, with locations in Tucson, Arizona, and San Bruno, California, our products support the health of patients in the areas of maternal health, anemia management and cancer supportive care. In addition, we help families preserve newborn stem cells, which are used today in transplant medicine for certain cancers and blood, immune and metabolic disorders and have the potential to play a valuable role in the ongoing development of regenerative medicine.

Along with driving organic growth of our products, we seek to leverage our existing commercial infrastructure with additional commercial-stage products in our two current therapeutic areas and may consider late-stage development assets or seek opportunities in new therapeutic areas.

Recent Event Webcasts

Webcast ImageWebcast
AMAG Pharmaceuticals, Inc. at Needham Healthcare Conference (Live)
April 04, 2017 at 4:20 p.m. ET
Webcast ImageWebcast
AMAG Pharmaceuticals, Inc. at Barclays Global Healthcare Conference (Replay)
March 14, 2017 at 2:35 p.m. ET
Webcast ImageWebcast
AMAG Pharmaceuticals, Inc. at Raymond James Institutional Investors Conference (Replay)
March 08, 2017 at 10:25 a.m. ET
Webcast ImageWebcast
AMAG Pharmaceuticals, Inc. at Cowen and Company Health Care Conference (Replay)
March 06, 2017 at 2:40 p.m. ET

Featured Presentations

  2016 AMAG Analyst Day Presentation